website logo

Category: research

In a Phase 3 small-cell lung cancer clinical trial in China, Shanghai Henliu Biotech, Inc. announced that the study met its primary endpoint. The study, assessing the use of first-line PD-1 inhibitor serplulimab plus chemotherapy in small-cell lung cancer (SCLC), indicated the combination improved the overall survival of participants. The successful results mean the study’s primary endpoint has been met.

Women receiving treatment in small-cell lung cancer clinical trial
Women receiving treatment in small-cell lung cancer clinical trial

Henlius Small-Cell Lung Cancer Clinical Trial Meets Primary Endpoint

By Rachel Ernst |

In a Phase 3 small-cell lung cancer clinical trial in China, Shanghai Henliu Biotech, Inc. announced that the study met its primary endpoint. The study, assessing the use of first-line PD-1 inhibitor serplulimab plus chemotherapy in small-cell lung cancer (SCLC), indicated the combination improved the overall survival of participants. The successful results mean the study’s primary endpoint has been met.

Read More

Male doctor examining mature man coughing

Is Stage 3 Lung Cancer Curable?

By Madeline May |

When lung cancer develops into stage 3, it has begun to spread beyond the original site. Medical professionals refer to this period as an advanced stage of lung cancer. Many people wonder though - is stage 3 lung cancer curable?

Read More

Lung cancer awareness ribbon that helps raise lung cancer donations.

Where Does Your Lung Cancer Donation Go?

By Rachel Ernst |

Finding organizations and sending donations is relatively easy. Once the payment has been sent, where does it go? Monetary gifts to lung cancer organizations serve a wide range of purposes, from research to education and advocacy.

Read More